SCHEMBL23065975

SCHEMBL23065975

Cc1ccc2c(c1Br)C(=O)N(C1CCC(=O)NC1=O)C2=O

nearest known ligand 0.70

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 19/20 0.70
▸ DDB1 Q16531 14/20 0.70
▸ IKZF3 Q9UKT9 2/20 0.60
▸ ALDH1A1 P00352 1/20 0.60
▸ CHRM2 P08172 1/20 0.60
▸ OPRM1 P35372 1/20 0.60
▸ CYP1A2 P05177 1/20 0.60
▸ TSHR P16473 1/20 0.60
▸ TDP1 Q9NUW8 1/20 0.60
▸ TNF P01375 2/20 0.60
▸ IL1B P01584 1/20 0.60
▸ TBXA2R P21731 1/20 0.60
▸ IKZF1 Q13422 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22580841 0.85 CRBN (0.70) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL24717672 0.85 CRBN (0.70) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL20811582 0.85 CRBN (0.73) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL24590557 0.85 CRBN (0.70) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL25650343 0.85 CRBN (0.70) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL29260153 0.84 CRBN (0.59) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL30938281 0.84 CRBN (0.59) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL2049325 0.84 CRBN (0.75) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL2049327 0.84 CRBN (0.75) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL2051062 0.84 CRBN (0.75) CRBNDDB1IKZF3ALDH1A1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4019021-A1 COMPOUND INHIBITING AND INDUCING DEGRADATION OF EGFR AND ALK Beijing Tide Pharmaceutical Co., Ltd. (CN) 2022-06-29 — — EP disclosed
WO-2021036922-A1 COMPOUND INHIBITING AND INDUCING DEGRADATION OF EGFR AND ALK 北京泰德制药股份有限公司 2021-03-04 — — WO disclosed
Send feedback